33 related articles for article (PubMed ID: 10843732)
1. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4.
Vella A; Teague TK; Ihle J; Kappler J; Marrack P
J Exp Med; 1997 Jul; 186(2):325-30. PubMed ID: 9221762
[TBL] [Abstract][Full Text] [Related]
2. Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.
Williams D; Hargrove-Wiley E; Bindeman W; Valent D; Miranda AX; Beckstead J; Fingleton B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731867
[TBL] [Abstract][Full Text] [Related]
3. Alteration of Immunoregulatory Patterns and Survival Advantage of Key Cell Types in Food Allergic Children.
Ivory K; Angotti R; Messina M; Bonente D; Paternostro F; Gulisano M; Nicoletti C
Cells; 2023 Nov; 12(23):. PubMed ID: 38067164
[TBL] [Abstract][Full Text] [Related]
4. Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression.
Paccagnella M; Abbona A; Michelotti A; Geuna E; Ruatta F; Landucci E; Denaro N; Vanella P; Lo Nigro C; Galizia D; Merlano M; Garrone O
Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062739
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.
Martin-Broto J; Mondaza-Hernandez JL; Moura DS; Hindi N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200924
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells.
Trinité B; Chan CN; Lee CS; Mahajan S; Luo Y; Muesing MA; Folkvord JM; Pham M; Connick E; Levy DN
PLoS One; 2014; 9(10):e110719. PubMed ID: 25330112
[TBL] [Abstract][Full Text] [Related]
7. An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.
Trinité B; Ohlson EC; Voznesensky I; Rana SP; Chan CN; Mahajan S; Alster J; Burke SA; Wodarz D; Levy DN
J Virol; 2013 Dec; 87(23):12701-20. PubMed ID: 24049167
[TBL] [Abstract][Full Text] [Related]
8. Integration of cytokine and heterologous receptor signaling pathways.
Bezbradica JS; Medzhitov R
Nat Immunol; 2009 Apr; 10(4):333-9. PubMed ID: 19295629
[TBL] [Abstract][Full Text] [Related]
9. PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.
Cho SH; Goenka S; Henttinen T; Gudapati P; Reinikainen A; Eischen CM; Lahesmaa R; Boothby M
Blood; 2009 Mar; 113(11):2416-25. PubMed ID: 19147789
[TBL] [Abstract][Full Text] [Related]
10. T-cell homeostasis in mice exposed to airborne xenobiotics.
Drela N; Bień J; Kozłowska E
Immunology; 2005 Apr; 114(4):476-83. PubMed ID: 15804284
[TBL] [Abstract][Full Text] [Related]
11. IL-4 signaling, gene transcription regulation, and the control of effector T cells.
Boothby M; Mora AL; Aronica MA; Youn J; Sheller JR; Goenka S; Stephenson L
Immunol Res; 2001; 23(2-3):179-91. PubMed ID: 11444383
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
Minshall C; Arkins S; Dantzer R; Freund GG; Kelley KW
J Immunol; 1999 Apr; 162(8):4542-9. PubMed ID: 10201993
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
14. An update on interleukin-4 and its receptor.
Chomarat P; Banchereau J
Eur Cytokine Netw; 1997 Dec; 8(4):333-44. PubMed ID: 9459612
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression, growth, and cell survival by IL-4: contribution of multiple signaling pathways.
Keegan AD; Zamorano J
Cell Res; 1998 Mar; 8(1):1-13. PubMed ID: 9570012
[TBL] [Abstract][Full Text] [Related]
16. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway.
Aronica MA; Goenka S; Boothby M
Cytokine; 2000 Jun; 12(6):578-87. PubMed ID: 10843732
[TBL] [Abstract][Full Text] [Related]
17. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
